The role of cyclic nucleotides in neutrophil migration

General Pharmacology

Volumn 27, Issue 2, 1996, Pages 387-393

  Elferink, Jan G R ^a   VanUffelen, Bart E ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ADRENALIN; ASCORBIC ACID; ATRIAL NATRIURETIC FACTOR; AURANOFIN; CALCIUM; CAPTOPRIL; CARBACHOL; CYCLIC AMP; CYCLIC GMP; DIBUTYRYL CYCLIC GMP; ENDOTHELIN; FORMYLMETHIONYLLEUCYLPHENYLALANINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; ISOPRENALINE; LEVAMISOLE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE INHIBITOR; NORADRENALIN; PENICILLAMINE; PEPTIDE; PHENYLEPHRINE; PHORBOL 13 ACETATE 12 MYRISTATE; PROSTAGLANDIN F2 ALPHA; SEROTONIN; TIOPRONIN; UNINDEXED DRUG;

CELL METABOLISM; CELL MOTILITY; CELL STRUCTURE; CONCENTRATION RESPONSE; DRUG MECHANISM; ELECTROPORATION; HUMAN; LEUKOCYTE MIGRATION; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0343844156     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-3623(95)00070-4     Document Type: Article

References (66)

1. Anand-Srivastava M. B. and Trachte G. J. (1993) Atrial natriuretic factor receptors and signal transduction mechanisms. Pharmac. Rev. 45, 455-497.
2. Anderson R., Glover A. and Rabson A. R. (1977) The in vitro effects of histamine and metiamide on neutrophil motility and their relationship to intracellular cyclic nucleotide levels. J. Immunol. 118, 1690-1696.
3. Anderson R. and Theron A. (1979) Effects of ascorbate on leukocytes. Part 1. Effects of ascorbate on neutrophil motility and intracellular cyclic nucleotide levels in vitro. S. Afri. Med. J. 56, 394-400.
4. Belenky S. N., Robbins R. A., Rennard S. I., Gossman G. L., Nelson, K. J. and Rubinstein, I. (1993). Inhibitors of nitric oxide synthase attenuate human neurotrophil chemotaxis in vitro. J. Lab. Clin. Med. 122, 388-394.
5. Bendzen K. and Palit J. (1977) In vitro modulation of human leucocyte migration and migration inhibitory factor (LIF) activity by cyclic 3′, 5′-AMP and cyclic 3′,5′-GMP. Acta Pathol. Microbiol. Scand. C 85, 78-80.
6. Bergman M. J., Guerrant R. L., Murad F., Richardson S. H., Weaver D. and Mandell G. L. (1978) Interaction of polymorphonuclear leukocytes with Escherichia coli. Effect of enterotoxin on phagocytosis, killing, chemotaxis, and cyclic AMP. J. Clin. Invest. 61, 227-234.
7. Boonen G. J. J. C., de Koster B. M. Van Steveninck J. and Elferink J. G. R. (1993) Neutrophil chemotaxis induced by the diacylglycerol kinase inhibitor R59022. Biochim. Biophys. Acta 1178, 97-102.
8. Coffey R. G., Davis J. S. and Djeu J. Y. (1988) Stimulation of guanylate cyclase activity and reduction of adenylate cyclase activity by granulocyte-macrophage colony-stimulating factor in human blood neutrophils. J. Immunol. 140, 2695-2701.
9. Daniels R. H., Bird I. N., Hill M. E. and Finnen M. J. (1993) Differential regulation of early phase and late phase responses in human neutrophils by cAMP. Biochem. Pharmac. 45, 1613-1620.
10. Debski B. F., Ranney R. R. and Carchman R. A. (1982) The alternative effect of isobutylmethylxanthine in hypofunctional human neutrophil chemotaxis. Biochem. Biophys. Res. Commun. 108, 1228-1234.
11. Della Bianca V., De Togni P., Grzeskowiak M., Vicenti L. M. and Di Virgilio F. (1986) Cyclic AMP inhibition of phosphoinositide turnover in human neutrophils. Biochim. Biophys. Acta 886, 441-447.
12. Devreotes P. N. and Zigmond S. H. (1988) Chemotaxis in eukaryotic cells: a focus on leukocytes and Dictyostelium. Annu. Rev. Cell Biol. 4, 649-686.
13. Elferink J. G. R. and de Koster B. M. (1991a) Glutathione-induced enhancement of neutrophil locomotion. Immunobiology 184, 25-36.
14. Elferink J. G. R. and de Koster B. M. (1991b) Stimulation of rabbit polymorphonuclear leukocyte locomotion by D-penicillamine. Biochem. Pharmac. 42, 1745-1750.
15. Elferink J. G. R. and de Koster B. M. (1992a) N-methyl-N′-nitro-N-nitrosoguanidine: the effect of migration and cGMP level of neutrophils. Toxicology 73, 45-52.
16. Elferink J. G. R. and de Koster B. M. (1992b) Tiopronin (2-mercaptopropionyl glycine) has chemokinetic and chemotactic properties for polymorphonuclear leukocytes, Immunopharmacology 23, 91-96.
17. Elferink J. G. R. and de Koster B. M. (1993a) The effect of cyclic GMP and cyclic AMP on migration by electroporated human neutrophils. Eur. J. Pharmac. 246, 157-161.
18. Elferink J. G. R. and de Koster B. M. (1993b) Modulation of neutrophil migration by captopril. Naunyn-Schmiedeberg's Arch. Pharmac. 347, 562-567.
19. Elferink J. G. R. and de Koster B. M. (1993c) Differential stimulation of neutrophil functions by pyrithioxine. Int. J. Immunopharmac. 15, 641-646.
20. Elferink J. G. R. and de Koster B. M. (1993d) Potentiation and inhibition of human neutrophil migration by auranofin. Ann. Rheum. Dis. 52, 595-598.
21. Elferink J. G. R. and de Koster B. M. (1994) Endothelin-induced activation of neutrophil migration. Biochem. Pharmac. 48, 865-871.
22. Elferink J. G. R. and de Koster B. M. (1995) Atrial natriuretic factor stimulates migration by human neutrophils. Eur. J. Pharmac. 288, 335-340.
23. Estensen R. D., Hill H. R., Quie P. G., Hogan N. and Goldberg N. D. (1973) Cyclic GMP and cell movement. Nature 245, 458-460.
24. Gabler W. L., Bullock W. W. and Creamer H. R. (1993) Phorbol myristate acetate induction of chemotactic migration of human polymorphonuclear neutrophils. Inflammation 17, 521-529.
25. 2+ in sea urchin eggs by stimulating cyclic ADP-ribose synthesis. Nature 365, 456-459.
26. Garbers D. L. (1992) Guanylyl cyclase receptors and their endocrine, paracrine, and autocrine ligands. Cell 74, 1-4.
27. Goetzl E. J., Wasserman S. I., Gigli I. and Austen K. F. (1974) Enhancement of random migration and chemotactic response of human leukocytes by ascorbic acid. J. Clin. Invest. 53, 813-818.
28. Gruetter C. A., Gruetter D. Y., Lyon J. E., Kadowitz P. J. and Ignarro L. J. (1981) Relationship between cyclic guanosine 3′:5′-monophosphate formation and relaxation of coronary arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrite and nitric oxide: effects of methylene blue and methemoglobin. J. Pharmacol. Exp. Ther. 219, 181-186.
29. Harvath L., Robbins J. D., Russell A. A. and Seamon K. B. (1991) cAMP and human neutrophil chemotaxis. Elevation of cAMP differentially affects chemotactic responsiveness. J. Immunol. 6, 224-232.
30. Hatch G. E., Nichols W. and Hill H. R. (1977) Cyclic nucleotide changes in human neutrophils induced by chemoattractants and chemotactic modulators. J. Immunol. 119, 450-456.
31. Hill H. R., Estensen R. D., Quie P. G., Hogan N. A. and Goldberg N. D. (1975) Modulation of human neutrophil chemotactic responses by cyclic 3′,5′-guanosine monophosphate and cyclic 3′,5′-adenosine monophosphate. Metabolism 24, 447-456.
32. Hirata M., Kohse K., Chang C. H., Ikebe T. and Murad F. (1990) Mechanism of cyclic GMP inhibition of inositol phosphate formation in rat aorta segments and cultured bovine aortic smooth muscle cells. J. Biol. Chem. 265, 1268-1273.
33. Housely M. D. (1984) Renaissance for cyclic GMP? TIBS, 465-466.
34. Jackowski S. and Sha'afi R. I. (1979) Response of adenosine cyclic 3′,5′-monophosphate level in rabbit neutrophils to the chemotactic peptide formyl-methionyl-leucyl-phenylalanine. Mol. Pharmac. 16, 473-481.
35. G-monomethyl-L-arginine: a role for cyclic GMP. Blood 74, 1885-1887.
36. Komalavilas P. and Lincoln T. M. (1994) Phosphorylation of the inositol 1,4,5-trisphosphate receptor by cyclic GMP-dependent protein kinase. J. Biol. Chem. 269, 8701-8707.
37. Kownatzki E., Liehl E., Aschauer H. and Uhrich S. (1990) Inhibition of chemotactic migration of human neutrophilic granulocytes by recombinant human granulocyte-macrophage colony-stimulating factor. Immunopharmacology 19, 139-143.
38. Kubes P., Suzuki M. and Granger D. N. (1991) Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. USA 88, 4651-4655.
39. Lad P. M., Glovsky M. M., Richards J. H., Smiley P. A. and Backstrom B. (1985) Regulation of human neutrophil guanylate cyclase by metal ions, free radicals, and the muscarinic cholinergic receptor. Mol. Immunol. 22, 731-739.
40. Lincoln T. M., Pryzwansky K. B., Cornwell T. L., Wyatt T. A. and MacMillan L. A. (1993) Cyclic-GMP-dependent protein kinase in smooth muscle and neutrophils. Adv. Sec. Messeng. Phosphoprotein Res. 28, 121-132.
41. Lopez Farre A., Riesco A., Moliz M., Egido J., Casado S., Hernando L. and Caramelo C. (1991) Inhibition by L-arginine of the endothelium-mediated increase in cytosolic calcium in human neutrophils. Biochem. Biophys. Res. Commun. 178, 884-891.
42. Moilanen E., Vorinene P., Kankaanranta H., Metsä-Ketelä T. and Vapaatalo H. (1993) Inhibition by nitric oxide donors of human polymorphonuclear leukocyte functions. J. Pharmacol. 109, 852-858.
43. Moncada S., Palmer R. J. J. and Higgs E. A. (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmac. Rev. 43: 109-142.
44. Oben J. A. and Foreman J. C. (1988) Stimulatory effects of antirheumatic drugs on human neutrophil functions. Immunopharmacology 16, 157-165.
45. Oben J. A., Wallace G. R., Chain B. M. and Foreman J. C. (1989) The stimulation of IL-2 production by antirheumatic drugs. Immunology 67, 328-332.
46. Pandol S. J. and Schoeffield-Payne M. S. (1990) Cyclic GMP mediates the agonist-stimulated increase in plasma membrane calcium entry in the pancreatic acinar cell. J. Biol. Chem. 265, 12846-12853.
47. Pryzwansky K. B., Steiner A. L., Spitznagel J. K. and Kapoor C. L. (1981) Compartmentalization of cyclic AMP during phagocytosis by human neutrophilic granulocytes. Science 211, 497-409.
48. Pryzwansky K. B., Wyatt T. A. and Lincoln T. M. (1990) Compartmentalization of cyclic GMP-dependent protein kinase in formyl-peptide stimulated neutrophils. Blood 76, 612-618.
49. Reibman J., Haines K. and Weissmann G. (1990) Alterations in cyclic nucleotides and the activation of neutrophils. In Current Topics in Membranes and Transport, Vol. 35 (Edited by A. Kleinzeller), pp. 399-424, Academic Press, San Diego, CA.
50. Riesco A., Caramelo C., Blum G., Monton M., Gallego M. J., Casado S. and Farre A. L. (1993) Nitric oxide-generating system as an autocrine mechanism in human polymorphonuclear leukocytes. Biochem. J. 292, 791-796.
51. Rivkin I. and Neutze J. A. (1977) Influence of cyclic nucleotides and a phosphodiesterase inhibitor on in vitro human blood neutrophil chemotaxis. Arch. Intern. Pharmacodyn. Ther. 228, 196-204.
52. Roch-Arveiller M., Tissot M., Moachon L. and Giroud J. P. (1982) Effect of immunomodulating agents on leukocyte chemotaxis and cyclic nucleotides. Agents Actions 12, 353-359.
53. Sandler J. A., Gallin J. I. and Vaughan M. (1975) Effects of serotonin, carbamylcholine, and ascorbic acid on leukocyte cyclic GMP and chemotaxis. J. Cell Biol. 67, 480-484.
54. Schmidt M. J., Sawyer B. D., Truex L. L., Marshall W. S. and Fleisch J. H. (1985) LY83583: an agent that lowers intracellular levels of cyclic guanosine 3′,5′-monophosphate. J. Pharmacol. Exp. Ther. 232, 764-769.
55. Schmidt H. H. H. W., Lohmann S. M. and Walter U. (1993) The nitric oxide and cGMP signal transduction system: regulation and mechanism of action. Biochim. Biophys. Acta. 1178, 153-175.
56. Seligmann B. E., Fletcher M. P. and Gallin J. I. (1983) Histamine modulation of human neutrophil oxidative metabolism, locomotion, degranulation, and membrane potential changes. J. Immunol. 130, 1902-1909.
57. Simchowitz L., Fischbein L. C., Spilbert I. and Atkinson J. P. (1980) Induction of a transient elevation in intracellular levels of adenosine-3′,5′-cyclic monophosphate by chemotactic factors: an early event in human neutrophil activation. J. Immunol. 124, 1482-1491.
58. Simchowitz L., Spilbert I. and Atkinson J. P. (1983) Evidence that the functional responses of human neutrophils occur independently of transient elevations in cyclic AMP levels. J. Nucleotide Prot. Phosphoryl. Res. 9, 35-47.
59. Smolen J. E., Korchak H. M. and Weissmann G. (1980) Increased levels of cyclic adenosine-3′,5′-monophosphate in human polymorphonuclear leukocytes after surface stimulation. J. Clin. Invest. 79, 1077-1085.
60. Tse R. L., Phelps P. and Urban D. (1972) Polymorphonuclear leukocyte motility in vitro. VI. Effect of purine and pyrimidine analogs: possible role of cyclic AMP. J. Lab. Clin. Med. 80, 264-274.
61. Wang J. M., Colella S., Allavena P. and Mantovani A. (1987) Chemotactic activity of human recombinant granulocyte-macrophage colony-stimulating factor. Immunology 60, 439-444.
62. Weidermann C. J., Niedermühlbichler M. and Braunsteiner H. (1992) Priming of polymorphonuclear neutrophils by atrial natriuretic peptide in vitro. J. Clin. Invest. 89, 1580-1586.
63. Wright D. G., Kirkpatrick C. H. and Gallin J. I. (1977). Effects of levanisole on normal and abnormal leukocyte locomotion. J. Clin. Invest. 59, 941-950.
64. Wyatt T. A., Lincoln T. M. and Pryzwansky K. B. (1991) Vimentin is transiently co-localized with an phosphorylated by cyclic GMP-dependent protein kinase in formyl-peptide-stimulated neutrophils. J. Biol. Chem. 266, 21274-21280.
65. Wyatt T. A., Lincoln T. M. and Pryzwansky K. B. (1993) Regulation of human neutrophil degranulation by LY-83583 and L-arginine: role of cGMP-dependent protein kinase. Am. J. Physiol. 265, C201-C211.
66. Yui Y., Hattori R., Kosuga K., Eizawa H., Hiki K., Ohkawa S., Ohnishi K., Terao S. and Kawai C. (1991) Calmodulin-independent nitric oxide synthase from rate polymorphonuclear neutrophils. J. Biol. Chem. 266, 3369-3371.